Effects of gender-affirming hormone therapy on gray matter density, microstructure and monoamine oxidase A levels in transgender subjects - Handschuh, PA; Reed, MB; Murgaš, M; Vraka, C; Kaufmann, U; Nics, L; Klöbl, M; Ozenil, M; Konadu, ME; Patronas, EM; Spurny-Dworak, B; Hahn, A; et al. (NeuroImage (Orlando, Fla.), 2024)
Keywords: Amine oxidase (flavin-containing); Brain; Cerebellum; Cingulum; Cisgender; Endocrine therapy; Estrogens; Females; Gender; Gender differences; Gender dysphoria; Gender identity; Gender-affirming care; Gender-affirming hormone therapy; Gray matter; Hormones; Magnetic resonance imaging; Metabolism; Morphology; Morphometry; MRI; Neuroimaging; Occipital lobe; Operculum; PET; Positron emission tomography; Sex chromosomes; Sexual desire; Steroids; Substantia grisea; Testosterone; Transgender persons; Sexual desire; MRI; Gray matter; PET; Gender-affirming hormone therapy; sexual desire; gender-affirming hormone therapy; gray matter